Anti-tenascin monoclonal antibody 81C6-I-131

N/A

Report date: 2025/09/08 17:55:36

Base Information

Drug NameAnti-tenascin monoclonal antibody 81C6-I-131
Drug Alias NameI-131 mAb81c6iodine I 131 monoclonal antibody 81C6Neuradiab
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Iodine > 131I +[5] 
Mechanisms of ActionIonising radiation emittersanti-Tenascin
TargetsTenascin
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDuke University Medical CenterBradmer Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke University Medical CenterBradmer Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A